Wave Life Sciences Competitors and Similar CompaniesClear all

Wave Life Sciences's competitors and similar companies include Vivet Therapeutics, Arrowhead Pharmaceuticals, RoukenBio and XCell Science.

	Wave Life Sciences Wave Life Sciences is a clinical stage genetic medicine company focused on advancing stereo pure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.	Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.	Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development.	RoukenBio RoukenBio (also known as Antibody Analytics) is a company that designs and develops bioassays to support biopharmaceutical development.	XCell Science XCell Science is a biotechnology company specialized in the production of neural cells from human pluripotent stem cells (PSCs).
Founding Date	Founding Date 2012	Founding Date 2016	Founding Date 2001	Founding Date 2015	Founding Date 2010
Type	Type Public	Type Private	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech drug development genetics life sciences
Locations	Locations Cambridge, US HQ Dublin 1, IE Kagoshima, JP Singapore, SG Birmingham, GB Lexington, US	Locations Paris, FR HQ	Locations Pasadena, US HQ Madison, US San Diego, US	Locations Motherwell, GB HQ	Locations Novato, US HQ Novato, US Novato, US
Employees	Employees 23522% decrease	Employees 195% decrease	Employees 13416% increase	Employees 937% increase	Employees 2
Valuation ($)	Valuation ($) 2.3 b	Valuation ($) N/A	Valuation ($) 2.5 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $42.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $829.4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($204.4m) (FY, 2025)	Net income N/A	Net income $30.1m (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Patents Issued	Patents Issued 27 (FY, 2016)	Patents Issued N/A	Patents Issued 359 (FY, 2016)	Patents Issued N/A	Patents Issued N/A
Funding
Total funding raised	Total funding raised $ 30m	Total funding raised $ 92.1m	Total funding raised $ 147.1m	Total funding raised N/A	Total funding raised N/A